[HTML][HTML] The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive …

D Goletti, G Delogu, A Matteelli, GB Migliori - International Journal of …, 2022 - Elsevier
ABSTRACT Objectives The World Health Organization estimated that a quarter of the global
population is infected by Mycobacterium tuberculosis (Mtb). A better control of tuberculosis …

A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis

NR Meier, M Jacobsen, THM Ottenhoff… - Frontiers in …, 2018 - frontiersin.org
Background: Current immunodiagnostic tests for tuberculosis (TB) are based on the
detection of an immune response toward mycobacterial antigens injected into the skin or …

[HTML][HTML] A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients

L Petrone, E Petruccioli, V Vanini, G Cuzzi… - Clinical microbiology …, 2021 - Elsevier
Objectives To examine whether specific T-cell-responses to SARS-CoV-2 peptides can be
detected in COVID-19 using a whole-blood experimental setting, which may be further …

Identification of antigens presented by MHC for vaccines against tuberculosis

P Bettencourt, J Müller, A Nicastri, D Cantillon… - npj Vaccines, 2020 - nature.com
Mycobacterium tuberculosis (M. tb) is responsible for more deaths globally than any other
pathogen. The only available vaccine, bacillus Calmette-Guérin (BCG), has variable efficacy …

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

D Goletti, L Petrone, G Ippolito, L Niccoli… - Expert Review of Anti …, 2018 - Taylor & Francis
Introduction: Latent tuberculosis infection (LTBI) accounts for almost a quarter of the world
population, and, in 5–10% of the subjects with impaired immune-response against M …

Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring

R Bayaa, MDB Ndiaye, C Chedid, E Kokhreidze… - Scientific Reports, 2021 - nature.com
There is a crucial need for non-sputum-based TB tests. Here, we evaluate the performance
of RISK6, a human-blood transcriptomic signature, for TB screening, triage and treatment …

Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children

M Sali, D Buonsenso, P D'Alfonso, F De Maio… - Journal of Infection, 2018 - Elsevier
Objectives Interferon-γ release assays (IGRA) are designed for diagnosis of tuberculosis
(TB) infection, and do not discriminate latent TB infection (LTBI) from active TB. Heparin …

Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic …

J Tang, Y Huang, Z Cai, Y Ma - PLoS One, 2021 - journals.plos.org
Background The Mycobacterial heparin-binding hemagglutinin (HBHA) is an important
latency-associated antigen that can be used to distinguish between latent tuberculosis …

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection

E Petruccioli, T Chiacchio, V Vanini, G Cuzzi… - Scientific Reports, 2018 - nature.com
Lack of biomarkers for treatment monitoring is listed among the main requirements for next
generation assays, as identified globally among tuberculosis (TB) researchers. In this study …

[HTML][HTML] Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV/M. tuberculosis-specific T-cell in co-infected subjects

T Chiacchio, E Petruccioli, V Vanini, G Cuzzi… - Immunology letters, 2018 - Elsevier
Abstract Background Human Immunodeficiency Virus (HIV) infection is a risk factor for
tuberculosis (TB). Antiretroviral therapy (ART) changed HIV clinical management but it is still …